Uemura H et al. |
Serum osteoprotegerin/osteoclastogenesis-inhibitory factor during pregnancy and lactation and the relationship with calcium-regulating hormones and bone turnover markers. |
2002 |
J. Endocrinol. |
pmid:12176675
|
Ragab AA et al. |
Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells. |
2002 |
Am. J. Physiol., Cell Physiol. |
pmid:12176725
|
Whyte MP et al. |
Osteoprotegerin deficiency and juvenile Paget's disease. |
2002 |
N. Engl. J. Med. |
pmid:12124406
|
Krane SM |
Genetic control of bone remodeling--insights from a rare disease. |
2002 |
N. Engl. J. Med. |
pmid:12124412
|
Suzuki Y et al. |
[Bone destruction and bone loss in rheumatoid arthritis--mechanism, prevention and treatment]. |
2002 |
Nippon Rinsho |
pmid:11979937
|
Inoue D |
[Recent advances in research of bone resorption]. |
2002 |
Nippon Rinsho |
pmid:11979946
|
Udagawa N and Takahashi N |
[Possible role of receptor activator of NF-kappa B ligand(RANKL) in osteoclast differentiation and function]. |
2002 |
Nippon Rinsho |
pmid:11979968
|
Tsuda E |
[Osteoclastogenesis inhibitory factor (OCIF)/OPG (a novel therapeutic candidate for the treatment of metabolic bone diseases)]. |
2002 |
Nippon Rinsho |
pmid:11979969
|
Koshihara Y |
[Recent progress of bone cell culture system (review)]. |
2002 |
Nippon Rinsho |
pmid:11979973
|
Kim YH et al. |
Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression. |
2002 |
Exp. Mol. Med. |
pmid:12085990
|
Khosla S et al. |
Correlates of osteoprotegerin levels in women and men. |
2002 |
Osteoporos Int |
pmid:12086350
|
Ueland T et al. |
Effects of 12 months of GH treatment on cortical and trabecular bone content of IGFs and OPG in adults with acquired GH deficiency: a double-blind, randomized, placebo-controlled study. |
2002 |
J. Clin. Endocrinol. Metab. |
pmid:12050246
|
Sasaki N et al. |
Changes in osteoprotegerin and markers of bone metabolism during glucocorticoid treatment in patients with chronic glomerulonephritis. |
2002 |
Bone |
pmid:12052453
|
Okada Y et al. |
Cell-to-Cell adhesion via intercellular adhesion molecule-1 and leukocyte function-associated antigen-1 pathway is involved in 1alpha,25(OH)2D3, PTH and IL-1alpha-induced osteoclast differentiation and bone resorption. |
2002 |
Endocr. J. |
pmid:12402981
|
Roodman GD |
Role of the bone marrow microenvironment in multiple myeloma. |
2002 |
J. Bone Miner. Res. |
pmid:12412796
|
Hegedus D et al. |
Decreased bone density, elevated serum osteoprotegerin, and beta-cross-laps in Wilson disease. |
2002 |
J. Bone Miner. Res. |
pmid:12412803
|
Ito S et al. |
Crystal structure of the extracellular domain of mouse RANK ligand at 2.2-A resolution. |
2002 |
J. Biol. Chem. |
pmid:11733492
|
Viereck V et al. |
Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts. |
2002 |
Biochem. Biophys. Res. Commun. |
pmid:11855844
|
Romas E et al. |
Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. |
2002 |
Bone |
pmid:11856640
|
Viereck V et al. |
Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts. |
2002 |
J. Cell. Biochem. |
pmid:11835398
|
Wise GE et al. |
Inhibition of osteoclastogenesis by the secretion of osteoprotegerin in vitro by rat dental follicle cells and its implications for tooth eruption. |
2002 |
Arch. Oral Biol. |
pmid:11839361
|
David JP et al. |
JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. |
2002 |
J. Cell. Sci. |
pmid:12376563
|
Jones DH et al. |
Role of RANKL and RANK in bone loss and arthritis. |
2002 |
Ann. Rheum. Dis. |
pmid:12379618
|
Gravallese EM |
Bone destruction in arthritis. |
2002 |
Ann. Rheum. Dis. |
pmid:12379632
|
Spyrou P et al. |
Cytokine release by osteoblast-like cells cultured on implant discs of varying alloy compositions. |
2002 |
Clin Oral Implants Res |
pmid:12519337
|
Saidenberg Kermanac'h N et al. |
Osteoprotegerin and inflammation. |
2002 Apr-Jun |
Eur. Cytokine Netw. |
pmid:12101070
|
Jung K et al. |
Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in the serum of healthy adults. |
2002 Jul-Sep |
Int. J. Biol. Markers |
pmid:12408468
|
Younes A and Aggarwall BB |
Clinical implications of the tumor necrosis factor family in benign and malignant hematologic disorders. |
2003 |
Cancer |
pmid:12879461
|
Nawroth P et al. |
[Osteoporosis and cardiovascular disease--two sides of the same coin?]. |
2003 |
Med. Klin. (Munich) |
pmid:12928809
|
Nakatsuka K et al. |
Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene. |
2003 |
J. Bone Miner. Res. |
pmid:12929927
|
Li JP and Ling JQ |
[Tumor necrosis factor and lipopolysaccharide affect periodontal ligament cells expressing osteoprotegerin in vitro]. |
2003 |
Zhonghua Kou Qiang Yi Xue Za Zhi |
pmid:12930661
|
Park HR et al. |
Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis. |
2003 |
J. Korean Med. Sci. |
pmid:12923331
|
Naylor KE et al. |
Serum osteoprotegerin as a determinant of bone metabolism in a longitudinal study of human pregnancy and lactation. |
2003 |
J. Clin. Endocrinol. Metab. |
pmid:14602774
|
Paloneva J et al. |
DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features. |
2003 |
J. Exp. Med. |
pmid:12925681
|
Fukushima H et al. |
Expression and role of RANKL in periodontal ligament cells during physiological root-resorption in human deciduous teeth. |
2003 |
Eur. J. Oral Sci. |
pmid:12887401
|
Ito R et al. |
Expression of osteoprotegerin correlates with aggressiveness and poor prognosis of gastric carcinoma. |
2003 |
Virchows Arch. |
pmid:12838418
|
Hayashi S et al. |
Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha. |
2003 |
J. Immunol. |
pmid:14607912
|
Terpos E et al. |
Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma. |
2003 |
Int. J. Cancer |
pmid:12845688
|
Padigel UM et al. |
TRANCE-RANK costimulation is required for IL-12 production and the initiation of a Th1-type response to Leishmania major infection in CD40L-deficient mice. |
2003 |
J. Immunol. |
pmid:14607948
|
Schett G et al. |
Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice. |
2003 |
Arthritis Rheum. |
pmid:12847699
|
Gruber HE and Rude RK |
Alterations in osteoclast morphology following osteoprotegerin administration in the magnesium-deficient mouse. |
2003 |
Biotech Histochem |
pmid:14989640
|
Wagner TU et al. |
The teleost fish medaka (Oryzias latipes) as genetic model to study gravity dependent bone homeostasis in vivo. |
2003 |
Adv Space Res |
pmid:15000082
|
Terpos E et al. |
New insights into the pathophysiology and management of bone disease in multiple myeloma. |
2003 |
Br. J. Haematol. |
pmid:14632767
|
Ha H et al. |
Lipid rafts are important for the association of RANK and TRAF6. |
2003 |
Exp. Mol. Med. |
pmid:14508068
|
Zhang L et al. |
The role of calmodulin in the regulation of osteoclastogenesis. |
2003 |
Endocrinology |
pmid:12960067
|
Abrahamsen B et al. |
Effects of the natural and artificial menstrual cycle on the production of osteoprotegerin and the bone resorptive cytokines IL-1beta and IL-6. |
2003 |
Calcif. Tissue Int. |
pmid:12384814
|
Hortobagyi GN |
Novel approaches to the management of bone metastases. |
2003 |
Semin. Oncol. |
pmid:14613037
|
Voskaridou E et al. |
Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia. |
2003 |
Br. J. Haematol. |
pmid:14616979
|
Uemura H et al. |
Circulating osteoprotegerin in women during GnRH-agonist treatment and their relationships with mineral components and biomarkers of bone turnover. |
2003 |
Bone |
pmid:14623063
|
Novack DV |
TSH, the bone suppressing hormone. |
2003 |
Cell |
pmid:14567908
|
Abe E et al. |
TSH is a negative regulator of skeletal remodeling. |
2003 |
Cell |
pmid:14567913
|
Zhao ZM et al. |
[The preliminary study on in vitro differentiation of human umbilical cord blood cells into neural cells]. |
2003 |
Zhonghua Xue Ye Xue Za Zhi |
pmid:14575594
|
Boyan BD et al. |
Osteoblasts generate an osteogenic microenvironment when grown on surfaces with rough microtopographies. |
2003 |
Eur Cell Mater |
pmid:14577052
|
Zhang J et al. |
Soluble receptor activator of nuclear factor kappaB Fc diminishes prostate cancer progression in bone. |
2003 |
Cancer Res. |
pmid:14633717
|
Chan BY et al. |
Effect of anticoagulants and storage temperature on the stability of receptor activator for nuclear factor-kappa B ligand and osteoprotegerin in plasma and serum. |
2003 |
Clin. Chem. |
pmid:14633883
|
Jung K et al. |
Serum osteoprotegerin and receptor activator of nuclear factor-kappa B ligand as indicators of disturbed osteoclastogenesis in patients with prostate cancer. |
2003 |
J. Urol. |
pmid:14634401
|
Su X et al. |
[The effects of 17 beta-estradiol on the expression of osteoprotegerin, the ligand of osteoprotegerin and related cytokines in osteosarcoma MG63 cells]. |
2003 |
Zhonghua Nei Ke Za Zhi |
pmid:14636471
|
Kanatani M et al. |
Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity. |
2003 |
J. Cell. Physiol. |
pmid:12767054
|
Takayanagi H |
[Crosstalk between the immune and skeletal system]. |
2003 |
Ryumachi |
pmid:14598653
|
Ha H et al. |
Membrane rafts play a crucial role in receptor activator of nuclear factor kappaB signaling and osteoclast function. |
2003 |
J. Biol. Chem. |
pmid:12637570
|
Ritchlin CT et al. |
Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. |
2003 |
J. Clin. Invest. |
pmid:12639988
|
Kido S et al. |
Expression of RANK is dependent upon differentiation into the macrophage/osteoclast lineage: induction by 1alpha,25-dihydroxyvitamin D3 and TPA in a human myelomonocytic cell line, HL60. |
2003 |
Bone |
pmid:12810169
|
Kikuchi T et al. |
Cot/Tpl2 is essential for RANKL induction by lipid A in osteoblasts. |
2003 |
J. Dent. Res. |
pmid:12821717
|
D'Elia HF et al. |
Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1. |
2003 |
Arthritis Res. Ther. |
pmid:12823855
|
Knudsen ST et al. |
Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications. |
2003 |
Eur. J. Endocrinol. |
pmid:12824864
|
Fox SW et al. |
The possible role of TGF-beta-induced suppressors of cytokine signaling expression in osteoclast/macrophage lineage commitment in vitro. |
2003 |
J. Immunol. |
pmid:12646633
|
Varsani H et al. |
Synovial dendritic cells in juvenile idiopathic arthritis (JIA) express receptor activator of NF-kappaB (RANK). |
2003 |
Rheumatology (Oxford) |
pmid:12649407
|
Wise GE et al. |
Regulation of osteoprotegerin gene expression in dental follicle cells. |
2003 |
J. Dent. Res. |
pmid:12651935
|
Schoppet M et al. |
Low serum levels of soluble RANK ligand are associated with the presence of coronary artery disease in men. |
2003 |
Circulation |
pmid:12654623
|
Nimmanapalli R and Bhalla K |
Targets in apoptosis signaling: promise of selective anticancer therapy. |
2003 |
Methods Mol. Biol. |
pmid:12777745
|
Cheung J et al. |
Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene. |
2003 |
J. Endocrinol. |
pmid:12773123
|
Nakamura H et al. |
Suppression of osteoblastic phenotypes and modulation of pro- and anti-apoptotic features in normal human osteoblastic cells under a vector-averaged gravity condition. |
2003 |
J. Med. Dent. Sci. |
pmid:12968638
|
Johnson-Pais TL et al. |
Determination of a minimal region of loss of heterozygosity on chromosome 18q21.33 in osteosarcoma. |
2003 |
Int. J. Cancer |
pmid:12673693
|
Zaidi M et al. |
Osteoclastogenesis, bone resorption, and osteoclast-based therapeutics. |
2003 |
J. Bone Miner. Res. |
pmid:12674320
|
Tanaka S et al. |
Signal transduction pathways regulating osteoclast differentiation and function. |
2003 |
J. Bone Miner. Metab. |
pmid:12720046
|
Valleala H et al. |
Effect of cyclical intermittent etidronate therapy on circulating osteoprotegerin levels in patients with rheumatoid arthritis. |
2003 |
Eur. J. Endocrinol. |
pmid:12720535
|
Yonou H et al. |
Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice. |
2003 |
Cancer Res. |
pmid:12727825
|
Capparelli C et al. |
Sustained antiresorptive effects after a single treatment with human recombinant osteoprotegerin (OPG): a pharmacodynamic and pharmacokinetic analysis in rats. |
2003 |
J. Bone Miner. Res. |
pmid:12733724
|
Wong T et al. |
Therapeutic implications for interferon-alpha in arthritis: a pilot study. |
2003 |
J. Rheumatol. |
pmid:12734885
|
Al-Qawasmi RA et al. |
Genetic predisposition to external apical root resorption in orthodontic patients: linkage of chromosome-18 marker. |
2003 |
J. Dent. Res. |
pmid:12709501
|
Fujita D et al. |
Prostaglandin E2 induced the differentiation of osteoclasts in mouse osteoblast-depleted bone marrow cells. |
2003 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12711253
|
Katavić V et al. |
Increased bone mass is a part of the generalized lymphoproliferative disorder phenotype in the mouse. |
2003 |
J. Immunol. |
pmid:12538719
|
Clohisy D |
Cellular mechanisms of osteolysis. |
2003 |
J Bone Joint Surg Am |
pmid:12540662
|
Vanderkerken K et al. |
Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma. |
2003 |
Cancer Res. |
pmid:12543775
|
Fahrleitner A et al. |
Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation. |
2003 |
Bone |
pmid:12584041
|
Lanzi R et al. |
GH replacement therapy increases plasma osteoprotegerin levels in GH-deficient adults. |
2003 |
Eur. J. Endocrinol. |
pmid:12590637
|
Shipman CM and Croucher PI |
Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells. |
2003 |
Cancer Res. |
pmid:12615702
|
Hamzei M et al. |
Osteoclast stimulating and differentiating factors in human cholesteatoma. |
2003 |
Laryngoscope |
pmid:12616193
|
Siggelkow H et al. |
Cytokines, osteoprotegerin, and RANKL in vitro and histomorphometric indices of bone turnover in patients with different bone diseases. |
2003 |
J. Bone Miner. Res. |
pmid:12619938
|
Toraldo G et al. |
IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. |
2003 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:12490655
|
Nishimura K et al. |
Effects of irradiation on cementum matrix cytokins function during periodontal regeneration. |
2003 |
Hum. Cell |
pmid:15147042
|
Choi BK et al. |
Induction of osteoclastogenesis and matrix metalloproteinase expression by the lipooligosaccharide of Treponema denticola. |
2003 |
Infect. Immun. |
pmid:12496170
|
Liu D et al. |
Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. |
2003 |
Int. J. Mol. Med. |
pmid:12469211
|
Takayanagi H |
[Signaling mechanism in the regulation of osteoclast differentiation by the immune system]. |
2003 |
Seikagaku |
pmid:14748148
|
Chen X et al. |
Effects of genistein on expression of bone markers during MC3T3-E1 osteoblastic cell differentiation. |
2003 |
J. Nutr. Biochem. |
pmid:12873716
|
Bridgham JT and Johnson AL |
Characterization of chicken TNFR superfamily decoy receptors, DcR3 and osteoprotegerin. |
2003 |
Biochem. Biophys. Res. Commun. |
pmid:12878204
|
Riggs BL et al. |
Evidence that type I osteoporosis results from enhanced responsiveness of bone to estrogen deficiency. |
2003 |
Osteoporos Int |
pmid:12879223
|
Crotti TN et al. |
Variability of RANKL and osteoprotegerin staining in synovial tissue from patients with active rheumatoid arthritis: quantification using color video image analysis. |
2003 |
J. Rheumatol. |
pmid:14677171
|
Sasaki T |
Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption. |
2003 |
Microsc. Res. Tech. |
pmid:12879416
|
Helfrich MH |
Osteoclast diseases. |
2003 |
Microsc. Res. Tech. |
pmid:12879419
|